Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Clubs
Explore
More
Language
English
English
ZK
Zsofia K. Stadler
Genetic factors in colorectal cancer
Memorial Sloan Kettering Cancer Center
Share
Follow
Claim This Profile
About
Research focus
Genetic factors in colorectal cancer
Impact
608 pubs · 27,152 cites · h-index 67
Affiliations
Memorial Sloan Kettering Cancer Center
Cornell University
Kettering University
See all
Publications
Recent publications by Zsofia K. Stadler
Microsatellite Instability Identifies a Rare but Clinically Relevant Subset of Sarcomas: Insights from the Largest Clinically Sequenced Cohort with Therapeutic Implications
Clinical Cancer Research · Thu,
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary Cancers
Mon,
Genetic testing in endometrial cancer (GenEC): A study on the patient experience with MSK-IMPACT.
Journal of Clinical Oncology · Thu,
Implementation of DPYD genotyping in response to FDA black box warning: Initial experience at a comprehensive cancer center.
Journal of Clinical Oncology · Thu,
Phase 2 study of adjuvant botensilimab in combination with balstilimab in patients with microsatellite-stable colorectal cancer and persistent circulating tumor DNA following surgery and chemotherapy.
Journal of Clinical Oncology · Thu,
Clinical impact of MSH3 loss-of-function alterations in patients treated with immune checkpoint blockade across cancer types.
Journal of Clinical Oncology · Wed,
A pilot study of a digital, patient-directed consent process for MSK-IMPACT tumor-normal genetic testing in gynecologic cancer.
Journal of Clinical Oncology · Wed,
Prevalence, tumor characteristics, and clinical impact of LZTR1 pathogenic variants in a large, pan-cancer cohort.
Journal of Clinical Oncology · Wed,
Functional assessment of polymerase proofreading variants to define sensitivity to immune checkpoint blockade (ICB) pan-cancer.
Journal of Clinical Oncology · Wed,
Expanded germline genetic testing of patients with hematologic malignancies to identify high proportion with hereditary cancer predisposition.
Journal of Clinical Oncology · Wed,